Simplification of Complex Physiologically Based Pharmacokinetic Models of Monoclonal Antibodies

被引:0
|
作者
Mohamed Elmeliegy
Philip Lowe
Wojciech Krzyzanski
机构
[1] University at Buffalo—State University of New York,Department of Pharmaceutical Sciences, School of Pharmacy & Pharmaceutical Sciences
[2] Novartis Pharma AG,undefined
来源
The AAPS Journal | 2014年 / 16卷
关键词
compartmental models; monoclonal antibodies; PBPK;
D O I
暂无
中图分类号
学科分类号
摘要
Monoclonal antibodies (mAbs) exhibit biexponential profiles in plasma that are commonly described with a standard two-compartment model with elimination from the central compartment. These models adequately describe mAb plasma PK. However, these models ignore elimination from the peripheral compartment. This may lead to underestimation of the volume of distribution of the peripheral compartment and thus over-predicts concentration in the peripheral compartment. We developed a simple and physiologically relevant model that incorporates information on binding and dissociation rates between mAb and FcRn receptor, mAb uptake, reflection, and catabolic degradation. We employed a previously published PBPK model and, with assumptions regarding rates of processes controlling mAb disposition, reduced the complex PBPK model to a simpler circular model with central, peripheral, and lymph compartments specifying elimination from both central and peripheral. We successfully applied the model to describe the PK of an investigational mAb. Our model presents an improvement over standard two-compartmental models in predicting whole-body average tissue concentrations while adequately describing plasma PK with minimal complexity and physiologically more meaningful parameters.
引用
收藏
页码:810 / 842
页数:32
相关论文
共 50 条
  • [21] Structural identifiability of physiologically based pharmacokinetic models
    Yates, JWT
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2006, 33 (04) : 421 - 439
  • [22] Physiologically Based Pharmacokinetic (PBPK) Models for Ethanol
    Plawecki, Martin H.
    Han, Jae-Joon
    Doerschuk, Peter C.
    Ramchandani, Vijay A.
    O'Connor, Sean J.
    IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING, 2008, 55 (12) : 2691 - 2700
  • [23] PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELS FOR DOSE ASSESSMENT
    BULLINGHAM, RES
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1992, 203 : 22 - CHAS
  • [24] An introduction to physiologically-based pharmacokinetic models
    Upton, Richard N.
    Foster, David J. R.
    Abuhelwa, Ahmad Y.
    PEDIATRIC ANESTHESIA, 2016, 26 (11) : 1036 - 1046
  • [25] Structural Identifiability of Physiologically Based Pharmacokinetic Models
    James W. T. Yates
    Journal of Pharmacokinetics and Pharmacodynamics, 2006, 33 : 421 - 439
  • [26] Scale-up of a physiologically-based pharmacokinetic model to predict the disposition of monoclonal antibodies in monkeys
    Patrick M. Glassman
    Yang Chen
    Joseph P. Balthasar
    Journal of Pharmacokinetics and Pharmacodynamics, 2015, 42 : 527 - 540
  • [28] SENSITIVITY ANALYSIS FOR PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELS
    HETRICK, DM
    JARABEK, AM
    TRAVIS, CC
    JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1991, 19 (01): : 1 - 20
  • [29] Incorporating target-mediated drug disposition in a minimal physiologically-based pharmacokinetic model for monoclonal antibodies
    Yanguang Cao
    William J. Jusko
    Journal of Pharmacokinetics and Pharmacodynamics, 2014, 41 : 375 - 387
  • [30] Application of population physiologically based pharmacokinetic modelling to optimize target expression and clearance mechanisms of therapeutic monoclonal antibodies
    Reig-Lopez, Javier
    Tang, Weifeng
    Fernandez-Teruel, Carlos
    Merino-Sanjuan, Matilde
    Mangas-Sanjuan, Victor
    Boulton, David W.
    Sharma, Pradeep
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (09) : 2691 - 2702